1332526-99-4

Basic information

• Product Name: 6-Bromo-1-phenyl-1,2-dihydro-indazol-3-one
• Synonyms: 6-Bromo-1-phenyl-1,2-dihydro-indazol-3-one
• CAS NO: 1332526-99-4
• Molecular Weight: 289.131
• Mol File: 1332526-99-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-Bromo-1-phenyl-1,2-dihydro-indazol-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Bromo-1-phenyl-1,2-dihydro-indazol-3-one(1332526-99-4)
• EPA Substance Registry System: 6-Bromo-1-phenyl-1,2-dihydro-indazol-3-one(1332526-99-4)

Safety Data

• Hazardous Substances Data: 1332526-99-4(Hazardous Substances Data)

Upstream product

• 1345403-94-2 2-Amino-4-bromo-benzoic acid N'-phenyl-hydrazide 
• 20776-50-5 2-amino-4-bromobenzoic acid 
• 76561-16-5 7-bromo-1,2-dihydro-3,1-4H-benzoxazine-2,4-dione 
• 100-63-0 phenylhydrazine 

Downstream Products

• 1345403-95-3 6-bromo-1-phenyl-1H-indazole-3-thiol 
• 1345404-13-8 4-[1-(3-Methylsulfanyl-1-phenyl-1H-indazol-6-yl)-azetidin-3-yl]-piperazine-1-carboxylic acid tert-butyl ester 
• 1345404-16-1 (4-(3-(methylthio)-1-phenyl-1H-indazol-6-yl)piperazin-1-yl)(pyridin-4-yl)methanone 
• 1345404-15-0 3-[4-(3-Methylsulfanyl-1-phenyl-1H-indazol-6-yl)-piperazine-1-carbonyl]-piperidine-1-carboxylic acid tert-butyl ester 
• 1345403-93-1 3-(methylsulfanyl)-1-phenyl-6-piperazin-1-yl-1H-indazole hydrochloride 
• 1332527-03-3 6-bromo-3-methoxy-1-phenyl-1H-indazole 
• 1332527-04-4 6-Bromo-3-methylsulfanyl-1-phenyl-1H-indazole 
• 1345403-95-3 C₁₃H₉BrN₂S 
• 1332526-61-0 3-methylsulfanyl-1-phenyl-6-(pyridin-4-yl)-1H-indazole 
• 1332526-60-9 3-methylsulfanyl-1-phenyl-6-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indazole 
• 1332526-71-2 (4-(3-(methylthio)-1-phenyl-1H-indazol-6-yl)piperazin-1-yl)(piperidin-4-yl)methanone 
• 1345403-96-4 4-(3-Methylsulfanyl-1-phenyl-1H-indazol-6-yl)-piperazine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS

The present invention is directed to substituted indazole compounds, pharmaceutical compositions of these compounds and methods of use thereof. The compounds of the present invention are ketohexokinase (KHK) inhibitors, useful for treating or ameliorating a KHK mediated metabolic disorders and/or diseases such as obesity, Type II diabetes mellitus and Metabolic Syndrome X.